Losigamone vs placebo
Proportion of participants experiencing adverse events · people with focal epilepsy
Losigamone showed no clear difference in the proportion of participants experiencing any adverse events compared with placebo (moderate certainty).
1 finding from 1 review
- RR 1.34 [1, 1.8]2 studies · 467 participantsModerate